Financhill
Buy
60

PM Quote, Financials, Valuation and Earnings

Last price:
$155.02
Seasonality move :
2.1%
Day range:
$154.01 - $155.76
52-week range:
$87.82 - $159.51
Dividend yield:
3.47%
P/E ratio:
34.22x
P/S ratio:
6.34x
P/B ratio:
--
Volume:
4.3M
Avg. volume:
6.6M
1-year change:
70.76%
Market cap:
$240B
Revenue:
$37.9B
EPS (TTM):
$4.51
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $28.7B $31.4B $31.8B $35.2B $37.9B
Revenue Growth (YoY) -3.73% 9.45% 1.14% 10.74% 7.69%
 
Cost of Revenues $9.6B $10B $11.4B $12.9B $13.3B
Gross Profit $19.1B $21.4B $20.4B $22.3B $24.5B
Gross Profit Margin 66.65% 68.06% 64.1% 63.35% 64.81%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $7.5B $8.4B $8.1B $10.1B $11.1B
Other Inc / (Exp) -- -$115M -$24M -$710M -$60M
Operating Expenses $7.6B $8.4B $8.1B $10.1B $11.1B
Operating Income $11.6B $13B $12.2B $12.2B $13.4B
 
Net Interest Expenses $618M $628M $588M $1.1B $1.1B
EBT. Incl. Unusual Items $11B $12.2B $11.6B $10.5B $12.2B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $2.4B $2.7B $2.2B $2.3B $3B
Net Income to Company $8.6B $9.7B $9.5B $8.3B $7.5B
 
Minority Interest in Earnings -$536M -$601M -$479M -$455M -$446M
Net Income to Common Excl Extra Items $8.1B $9.1B $9B $7.8B $7.1B
 
Basic EPS (Cont. Ops) $5.16 $5.83 $5.82 $5.02 $4.53
Diluted EPS (Cont. Ops) $5.16 $5.83 $5.81 $5.02 $4.52
Weighted Average Basic Share $1.6B $1.6B $1.6B $1.6B $1.6B
Weighted Average Diluted Share $1.6B $1.6B $1.6B $1.6B $1.6B
 
EBITDA $12.7B $14B $13.5B $13.4B $15.7B
EBIT $11.7B $13B $12.4B $12B $14B
 
Revenue (Reported) $28.7B $31.4B $31.8B $35.2B $37.9B
Operating Income (Reported) $11.6B $13B $12.2B $12.2B $13.4B
Operating Income (Adjusted) $11.7B $13B $12.4B $12B $14B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $7.4B $8.1B $8.2B $9B $9.7B
Revenue Growth (YoY) -3.49% 8.87% 0.59% 10.98% 7.28%
 
Cost of Revenues $2.6B $2.8B $3.2B $3.5B $3.4B
Gross Profit $4.9B $5.3B $4.9B $5.6B $6.3B
Gross Profit Margin 65.45% 65.36% 60.61% 61.73% 64.73%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $2B $2.4B $2B $2.7B $3B
Other Inc / (Exp) -- -$33M -$8M -$9M -$16M
Operating Expenses $2B $2.4B $2B $2.7B $3B
Operating Income $2.9B $2.9B $2.9B $2.9B $3.3B
 
Net Interest Expenses $164M $146M $170M $273M $326M
EBT. Incl. Unusual Items $2.7B $2.8B $2.7B $2.6B $2.9B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $613M $593M $409M $320M $872M
Net Income to Company $2.1B $2.2B $2.5B $2.3B -$486M
 
Minority Interest in Earnings -$143M -$136M -$97M -$117M -$93M
Net Income to Common Excl Extra Items $2B $2.1B $2.4B $2.2B -$579M
 
Basic EPS (Cont. Ops) $1.27 $1.34 $1.54 $1.41 -$0.38
Diluted EPS (Cont. Ops) $1.27 $1.34 $1.54 $1.41 -$0.38
Weighted Average Basic Share $1.6B $1.6B $1.6B $1.6B $1.6B
Weighted Average Diluted Share $1.6B $1.6B $1.6B $1.6B $1.6B
 
EBITDA $3.3B $3.3B $3.3B $3.7B $4.3B
EBIT $3B $3B $3.1B $3.3B $3.9B
 
Revenue (Reported) $7.4B $8.1B $8.2B $9B $9.7B
Operating Income (Reported) $2.9B $2.9B $2.9B $2.9B $3.3B
Operating Income (Adjusted) $3B $3B $3.1B $3.3B $3.9B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $28.7B $31.4B $31.8B $35.2B $37.9B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $9.6B $10B $11.4B $12.9B $13.3B
Gross Profit $19.1B $21.4B $20.4B $22.3B $24.5B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $7.5B $8.4B $8.1B $10.1B $11.1B
Other Inc / (Exp) -- -$115M -$24M -$710M -$60M
Operating Expenses $7.6B $8.4B $8.1B $10.1B $11.1B
Operating Income $11.6B $13B $12.2B $12.2B $13.4B
 
Net Interest Expenses $618M $628M $588M $1.1B $1.1B
EBT. Incl. Unusual Items $11B $12.2B $11.6B $10.5B $12.2B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $2.4B $2.7B $2.2B $2.3B $3B
Net Income to Company $8.6B $9.7B $9.5B $8.3B $7.5B
 
Minority Interest in Earnings -$536M -$601M -$479M -$455M -$446M
Net Income to Common Excl Extra Items $8.1B $9.1B $9B $7.8B $7.1B
 
Basic EPS (Cont. Ops) $5.17 $5.83 $5.82 $5.02 $4.52
Diluted EPS (Cont. Ops) $5.17 $5.83 $5.81 $5.02 $4.51
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $12.7B $14B $13.5B $13.4B $15.7B
EBIT $11.7B $13B $12.4B $12B $14B
 
Revenue (Reported) $28.7B $31.4B $31.8B $35.2B $37.9B
Operating Income (Reported) $11.6B $13B $12.2B $12.2B $13.4B
Operating Income (Adjusted) $11.7B $13B $12.4B $12B $14B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $31.4B $31.8B $35.2B $37.9B --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $10B $11.4B $12.9B $13.3B --
Gross Profit $21.4B $20.4B $22.3B $24.5B --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $8.4B $8.1B $10.1B $11.1B --
Other Inc / (Exp) -$115M -$24M -$710M -$60M --
Operating Expenses $8.4B $8.1B $10.1B $11.1B --
Operating Income $13B $12.2B $12.2B $13.4B --
 
Net Interest Expenses $628M $588M $1.1B $1.1B --
EBT. Incl. Unusual Items $12.2B $11.6B $10.5B $12.2B --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $2.7B $2.2B $2.3B $3B --
Net Income to Company $9.7B $9.5B $8.3B $7.5B --
 
Minority Interest in Earnings -$601M -$479M -$455M -$446M --
Net Income to Common Excl Extra Items $9.1B $9B $7.8B $7.1B --
 
Basic EPS (Cont. Ops) $5.83 $5.82 $5.02 $4.52 --
Diluted EPS (Cont. Ops) $5.83 $5.81 $5.02 $4.51 --
Weighted Average Basic Share $6.2B $6.2B $6.2B $6.2B --
Weighted Average Diluted Share $6.2B $6.2B $6.2B $6.2B --
 
EBITDA $14B $13.5B $13.4B $15.7B --
EBIT $13B $12.4B $12B $14B --
 
Revenue (Reported) $31.4B $31.8B $35.2B $37.9B --
Operating Income (Reported) $13B $12.2B $12.2B $13.4B --
Operating Income (Adjusted) $13B $12.4B $12B $14B --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $7.3B $4.5B $3.2B $3.1B $4.2B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $2.9B $3.1B $3.9B $3.5B $3.8B
Inventory $9.6B $8.7B $9.9B $10.8B $9.5B
Prepaid Expenses -- -- -- -- --
Other Current Assets $860M $561M $1.8B $1.5B $1.8B
Total Current Assets $21.5B $17.7B $19.6B $19.8B $20.2B
 
Property Plant And Equipment $6.4B $6.2B $6.7B $7.5B $7.3B
Long-Term Investments $4.8B $4.5B $4.4B $4.9B $2.7B
Goodwill $6B $6.7B $19.7B $16.8B $16.6B
Other Intangibles $2B $2.8B $6.7B $9.9B $11.3B
Other Long-Term Assets $2.8B $2.5B $3.9B $5.6B $2.8B
Total Assets $44.8B $41.3B $61.7B $65.3B $61.8B
 
Accounts Payable $2.8B $3.3B $4.1B $4.1B $4B
Accrued Expenses $2.9B $2.4B $3.4B $3.6B $3.8B
Current Portion Of Long-Term Debt $3.1B $2.8B $2.6B $4.7B $3.4B
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $19.6B $19.3B $27.3B $26.4B $22.9B
 
Long-Term Debt $28.2B $24.8B $34.9B $41.2B $42.2B
Capital Leases -- -- -- -- --
Total Liabilities $55.4B $49.5B $68B $74.8B $71.7B
 
Common Stock -- -- -- -- --
Other Common Equity Adj -$11.2B -$9.6B -$9.6B -$11.8B -$11.3B
Common Equity -$12.6B -$10.1B -$9B -$11.2B -$11.8B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $1.9B $1.9B $2.6B $1.8B $1.9B
Total Equity -$10.6B -$8.2B -$6.3B -$9.4B -$9.9B
 
Total Liabilities and Equity $44.8B $41.3B $61.7B $65.3B $61.8B
Cash and Short Terms $7.3B $4.5B $3.2B $3.1B $4.2B
Total Debt $31.5B $27.8B $43.1B $47.9B $45.7B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $7.3B $4.5B $3.2B $3.1B $4.2B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $2.9B $3.1B $3.9B $3.5B $3.8B
Inventory $9.6B $8.7B $9.9B $10.8B $9.5B
Prepaid Expenses -- -- -- -- --
Other Current Assets $860M $561M $1.8B $1.5B $1.8B
Total Current Assets $21.5B $17.7B $19.6B $19.8B $20.2B
 
Property Plant And Equipment $6.4B $6.2B $6.7B $7.5B $7.3B
Long-Term Investments $4.8B $4.5B $4.4B $4.9B $2.7B
Goodwill $6B $6.7B $19.7B $16.8B $16.6B
Other Intangibles $2B $2.8B $6.7B $9.9B $11.3B
Other Long-Term Assets $2.8B $2.5B $3.9B $5.6B $2.8B
Total Assets $44.8B $41.3B $61.7B $65.3B $61.8B
 
Accounts Payable $2.8B $3.3B $4.1B $4.1B $4B
Accrued Expenses $2.9B $2.4B $3.4B $3.6B $3.8B
Current Portion Of Long-Term Debt $3.1B $2.8B $2.6B $4.7B $3.4B
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $19.6B $19.3B $27.3B $26.4B $22.9B
 
Long-Term Debt $28.2B $24.8B $34.9B $41.2B $42.2B
Capital Leases -- -- -- -- --
Total Liabilities $55.4B $49.5B $68B $74.8B $71.7B
 
Common Stock -- -- -- -- --
Other Common Equity Adj -$11.2B -$9.6B -$9.6B -$11.8B -$11.3B
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $1.9B $1.9B $2.6B $1.8B $1.9B
Total Equity -$10.6B -$8.2B -$6.3B -$9.4B -$9.9B
 
Total Liabilities and Equity $44.8B $41.3B $61.7B $65.3B $61.8B
Cash and Short Terms $7.3B $4.5B $3.2B $3.1B $4.2B
Total Debt $31.5B $27.8B $43.1B $47.9B $45.7B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $8.6B $9.7B $9.5B $8.3B $7.5B
Depreciation & Amoritzation $981M $998M $1.1B $1.4B $1.8B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $26M -$198M -$871M $314M -$738M
Change in Inventories -$165M $549M -$1.3B -$862M $552M
Cash From Operations $9.8B $12B $10.8B $9.2B $12.2B
 
Capital Expenditures $602M $748M $1.1B $1.3B $1.4B
Cash Acquisitions -$47M -$2.1B -$14B $80M $55M
Cash From Investing -$1.2B -$2.4B -$15.7B -$3.6B -$1.1B
 
Dividends Paid (Ex Special Dividend) -$7.4B -$7.6B -$7.8B -$8B -$8.2B
Special Dividend Paid
Long-Term Debt Issued $3.8B -- $21.7B $11.9B $8.2B
Long-Term Debt Repaid -$4.1B -$3B -$7.5B -$8.2B -$9.9B
Repurchase of Common Stock -- -$775M -$209M -- --
Other Financing Activities -$776M -$580M -$2.3B -$1.3B $339M
Cash From Financing -$8.5B -$12B $3.8B -$5.6B -$9.5B
 
Beginning Cash (CF) $6.9B $7.3B $4.5B $3.2B $3.1B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $162M -$2.4B -$1.1B $24M $1.6B
Ending Cash (CF) $7.3B $4.5B $3.2B $3.1B $4.3B
 
Levered Free Cash Flow $9.2B $11.2B $9.7B $7.9B $10.8B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $2.1B $2.2B $2.5B $2.3B -$486M
Depreciation & Amoritzation $272M $279M $179M $369M $477M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $167M $156M $92M $581M $249M
Change in Inventories -$988M -$686M -$2.1B -$681M -$713M
Cash From Operations $3.2B $4B $3.1B $3.3B $4B
 
Capital Expenditures $140M $289M $347M $311M $278M
Cash Acquisitions -$44M -$250M -$14B $2B $135M
Cash From Investing -$586M -$340M -$15.5B -$568M $441M
 
Dividends Paid (Ex Special Dividend) -$1.9B -$2B -$2B -$2B -$2.1B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $1.5B -- $18.3B $431M $2.9B
Long-Term Debt Repaid $89M -$1B -$4.7B -$1.1B -$5.6B
Repurchase of Common Stock -- -$681M -- -- --
Other Financing Activities -$158M -$123M -$1.7B -$170M $654M
Cash From Financing -$465M -$3.8B $9.9B -$2.9B -$4.1B
 
Beginning Cash (CF) $4.8B $4.8B $5.4B $3B $4.3B
Foreign Exchange Rate Adjustment $347M -$191M $401M $275M -$387M
Additions / Reductions $2.1B -$109M -$2.6B -$163M $340M
Ending Cash (CF) $7.3B $4.5B $3.2B $3.1B $4.3B
 
Levered Free Cash Flow $3B $3.7B $2.7B $3B $3.7B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $8.6B $9.7B $9.5B $8.3B $7.5B
Depreciation & Amoritzation $981M $998M $1.1B $1.4B $1.8B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $26M -$198M -$871M $314M -$738M
Change in Inventories -$165M $549M -$1.3B -$862M $552M
Cash From Operations $9.8B $12B $10.8B $9.2B $12.2B
 
Capital Expenditures $602M $748M $1.1B $1.3B $1.4B
Cash Acquisitions -$47M -$2.1B -$14B $80M $55M
Cash From Investing -$1.2B -$2.4B -$15.7B -$3.6B -$1.1B
 
Dividends Paid (Ex Special Dividend) -$7.4B -$7.6B -$7.8B -$8B -$8.2B
Special Dividend Paid
Long-Term Debt Issued $3.8B -- $21.7B $11.9B $8.2B
Long-Term Debt Repaid -$4.1B -$3B -$7.5B -$8.2B -$9.9B
Repurchase of Common Stock -- -$775M -$209M -- --
Other Financing Activities -$776M -$580M -$2.3B -$1.3B $339M
Cash From Financing -$8.5B -$12B $3.8B -$5.6B -$9.5B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $162M -$2.4B -$1.1B $24M $1.6B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $9.2B $11.2B $9.7B $7.9B $10.8B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders $9.7B $9.5B $8.3B $7.5B --
Depreciation & Amoritzation $998M $1.1B $1.4B $1.8B --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$198M -$871M $314M -$738M --
Change in Inventories $549M -$1.3B -$862M $552M --
Cash From Operations $12B $10.8B $9.2B $12.2B --
 
Capital Expenditures $748M $1.1B $1.3B $1.4B --
Cash Acquisitions -$2.1B -$14B $80M $55M --
Cash From Investing -$2.4B -$15.7B -$3.6B -$1.1B --
 
Dividends Paid (Ex Special Dividend) -$7.6B -$7.8B -$8B -$8.2B --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $21.7B $11.9B $8.2B --
Long-Term Debt Repaid -$3B -$7.5B -$8.2B -$9.9B --
Repurchase of Common Stock -$775M -$209M -- -- --
Other Financing Activities -$580M -$2.3B -$1.3B $339M --
Cash From Financing -$12B $3.8B -$5.6B -$9.5B --
 
Beginning Cash (CF) $20.9B $19.5B $12.2B $16.4B --
Foreign Exchange Rate Adjustment -$417M -$213M -$95M -$536M --
Additions / Reductions -$2.4B -$1.1B $24M $1.6B --
Ending Cash (CF) $18.1B $18.3B $12.1B $17.5B --
 
Levered Free Cash Flow $11.2B $9.7B $7.9B $10.8B --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did HealthEquity Stock Fall So Much?
Why Did HealthEquity Stock Fall So Much?

HealthEquity (NASDAQ:HQY) is a fintech company that acts as an…

Why Did Super Micro Stock Fall So Much?
Why Did Super Micro Stock Fall So Much?

Super Micro Computer (NASDAQ:SMCI) was once a highly popular stock…

Is Diamondback Energy a Good Stock to Buy?
Is Diamondback Energy a Good Stock to Buy?

Diamondback Energy (FANG) is a lesser-known diamond in the rough…

Stock Ideas

Buy
56
Is AAPL Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 37x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Sell
46
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Buy
69
CNXC alert for Mar 28

Concentrix [CNXC] is up 42.45% over the past day.

Buy
74
SLNO alert for Mar 27

Soleno Therapeutics [SLNO] is up 37.64% over the past day.

Buy
68
WOR alert for Mar 27

Worthington Enterprises [WOR] is up 0.16% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock